Matches in Nanopublications for { <http://www.nextprot.org/nanopubs#NX_P15941-16_MUTAGEN_154_154.RAHqJ_Ji5nF96_R8TtuFMb8d2hIF9B5ZQ7nqTvZBtZlUw._1> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NX_P15941-16_MUTAGEN_154_154.RAHqJ_Ji5nF96_R8TtuFMb8d2hIF9B5ZQ7nqTvZBtZlUw._1 type RangedSequencePosition NX_P15941-16_MUTAGEN_154_154.RAHqJ_Ji5nF96_R8TtuFMb8d2hIF9B5ZQ7nqTvZBtZlUw.assertion.
- NX_P15941-16_MUTAGEN_154_154.RAHqJ_Ji5nF96_R8TtuFMb8d2hIF9B5ZQ7nqTvZBtZlUw._1 type SO_0001148 NX_P15941-16_MUTAGEN_154_154.RAHqJ_Ji5nF96_R8TtuFMb8d2hIF9B5ZQ7nqTvZBtZlUw.assertion.
- NX_P15941-16_MUTAGEN_154_154.RAHqJ_Ji5nF96_R8TtuFMb8d2hIF9B5ZQ7nqTvZBtZlUw._1 comment "Reduces binding to AP1S2 by 33%. Greatly reduced binding to GRB2. Reduced endocytosis by 50%. Reduced endocytosis by 77%; when associated with N-1203." NX_P15941-16_MUTAGEN_154_154.RAHqJ_Ji5nF96_R8TtuFMb8d2hIF9B5ZQ7nqTvZBtZlUw.assertion.
- NX_P15941-16_MUTAGEN_154_154.RAHqJ_Ji5nF96_R8TtuFMb8d2hIF9B5ZQ7nqTvZBtZlUw._1 SIO_000053 NX_P15941-16_MUTAGEN_154_154.RAHqJ_Ji5nF96_R8TtuFMb8d2hIF9B5ZQ7nqTvZBtZlUw._3 NX_P15941-16_MUTAGEN_154_154.RAHqJ_Ji5nF96_R8TtuFMb8d2hIF9B5ZQ7nqTvZBtZlUw.assertion.
- NX_P15941-16_MUTAGEN_154_154.RAHqJ_Ji5nF96_R8TtuFMb8d2hIF9B5ZQ7nqTvZBtZlUw._1 SIO_000053 NX_P15941-16_MUTAGEN_154_154.RAHqJ_Ji5nF96_R8TtuFMb8d2hIF9B5ZQ7nqTvZBtZlUw._2 NX_P15941-16_MUTAGEN_154_154.RAHqJ_Ji5nF96_R8TtuFMb8d2hIF9B5ZQ7nqTvZBtZlUw.assertion.